| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Uterine Cancer
|
NCI
|
5R01CA102590-04
|
|
Biointeractions of antiestrogens with nitric oxide
|
THATCHER, GREGORY
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$229,652
|
|
Uterine Cancer
|
NCI
|
5R01CA100441-05
|
|
A Murine Model for Endometrial Tumorigenesis
|
GOODFELLOW, PAUL
|
WASHINGTON UNIVERSITY
|
MO
|
$267,657
|
|
Uterine Cancer
|
NCI
|
5R01CA104875-05
|
|
THE ROLE OF PROTEIN KINASE C IN ENDOMETRIAL CANCER
|
BRADFORD, ANDREW
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$299,342
|
|
Uterine Cancer
|
NCI
|
5R01CA109379-05
|
|
SERM Regulation of PAK Pathway in Endometrial Cancer
|
KUMAR, RAKESH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$293,511
|
|
Uterine Cancer
|
NINDS
|
5R01NS038809-09
|
|
Beta Endorphin Neurons and the Control of Homeostasis
|
KELLY, MARTIN
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$331,093
|
|
Uterine Cancer
|
NCI
|
1R41CA121740-01A2
|
|
Image-Guided High-Intensity Interstitial Ultrasound for Thermal Ablation of Uteri
|
DIEDERICH, CHRIS
|
ACOUSTIC MEDSYSTEMS, INC.
|
IL
|
$149,948
|
|
Uterine Cancer
|
NCI
|
5R01CA100833-05
|
|
Hormonal modulation of latent endometrial precancers
|
MUTTER, GEORGE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$257,238
|
|
Uterine Cancer
|
NCI
|
5R01CA108612-04
|
|
Cytochrome-P-450 genes in pathobiology of endometrial cancer
|
DAHIYA, RAJVIR
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$283,708
|
|
Uterine Cancer
|
NCI
|
5R01CA071754-11
|
|
Defective DNA Mismatch Repair in Endometrial Cancers
|
GOODFELLOW, PAUL
|
WASHINGTON UNIVERSITY
|
MO
|
$277,450
|
|
Uterine Cancer
|
NICHD
|
1R01HD057873-01
|
|
Steroid Hormone Regulation of Uterine Function and Dysfunction
|
JEONG, JAE-WOOK
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$260,950
|
|
Uterine Cancer
|
NICHD
|
1R01HD050614-01A2
|
|
Progesterone Action in the Uterus of Mice and Humans
|
POLLARD, JEFFREY
|
YESHIVA UNIVERSITY
|
NY
|
$352,750
|
|
Uterine Cancer
|
NCCAM
|
5U01AT001653-06
|
|
Phytoestrogens and Progression of Atherosclerosis
|
HODIS, HOWARD
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$567,416
|
|
Uterine Cancer
|
OD
|
5U01AT001653-06
|
|
Phytoestrogens and Progression of Atherosclerosis
|
HODIS, HOWARD
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$107,725
|
|
Uterine Cancer
|
NCI
|
2R01CA097097-05A1
|
|
PTEN and the molecular genetics of endometrial cancer
|
DI CRISTOFANO, ANTONIO
|
FOX CHASE CANCER CENTER
|
PA
|
$344,347
|
|
Uterine Cancer
|
NCI
|
1R01CA125427-01A2
|
|
Extranuclear estrogen receptor actions on endometrial cancer cell proliferation
|
JACKSON, TWILA
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$287,440
|
|
Uterine Cancer
|
NCI
|
5K07CA117979-03
|
|
Inflamation and the Risk of Endometrial Cancer
|
VISWANATHAN, AKILA
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$134,490
|
|
Uterine Cancer
|
NCI
|
5F31CA113280-04
|
|
Genetic and Molecular Studies of Endometrial Cancer
|
CONTRERAS, CRISTINA
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$29,971
|
|
Uterine Cancer
|
NCI
|
5R01CA118743-02
|
|
The Role of GPR30 in Advanced Endometrial Cancer
|
PROSSNITZ, ERIC
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$285,000
|
|
Uterine Cancer
|
NCRR
|
5K26RR024196-02
|
|
Mentoring and Research in Mouse Models of Cancer and Infertility
|
CASTRILLON, DIEGO
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$120,262
|
|
Uterine Cancer
|
NCI
|
5R13CA113095-05
|
|
Annual Uterine Cancer Symposium
|
LU, KAREN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$971
|
|
Uterine Cancer
|
NCI
|
5R01CA109919-05
|
|
Social Cognitive Theory and PA after Endometrial Cancer
|
BASEN-ENGQUIST, KAREN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$259,754
|
|
Uterine Cancer
|
OD
|
5R01CA109919-05
|
|
Social Cognitive Theory and PA after Endometrial Cancer
|
BASEN-ENGQUIST, KAREN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$104,513
|
|
Uterine Cancer
|
NCI
|
5R01CA082838-09
|
|
Genetic Susceptibility to Endometrial Cancer
|
DEVIVO, IMMACULATA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$325,450
|
|
Uterine Cancer
|
NCI
|
5R03CA130108-02
|
|
Risk and prognosis of uterine corpus cancer after tamoxifen treatment for breast
|
VAN LEEUWEN, FLORA
|
NETHERLANDS CANCER INSTITUTE
|
NETH
|
$54,734
|
|
Uterine Cancer
|
NCI
|
5R03CA132190-02
|
|
Telomere Length and Endometrial Cancer
|
DEVIVO, IMMACULATA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$87,500
|
|
Uterine Cancer
|
NCI
|
1K01CA134550-01
|
|
Determinants of Exercise Adherence for Hispanic Cancer Survivor
|
HUGHES, DANIEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$115,272
|
|
Uterine Cancer
|
NCI
|
1R03CA128008-01A2
|
|
Genetic Variation in Estrogen Sulfation Genes and Endometrial Cancer Risk
|
SETIAWAN, VERONICA
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$81,500
|
|
Uterine Cancer
|
NCI
|
1R01CA128571-01A2
|
|
Embryonic Stem Cell Properties in Cancer
|
MERRILL, BRADLEY
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$318,641
|
|
Uterine Cancer
|
NCI
|
2R01CA099908-06A1
|
|
Targeted Therapy for Endometrial Cancer
|
LESLIE, KIMBERLY
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$313,900
|
|
Uterine Cancer
|
NCI
|
1R01CA127731-01A2
|
|
Development of GPR30-Selective Ligands
|
PROSSNITZ, ERIC
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$322,551
|
|
Uterine Cancer
|
NCI
|
1R21CA127674-01A2
|
|
Interaction of FOXO1 and Progesterone Receptor in Endometrial Cancer
|
KIM, JI-YONG
|
NORTHWESTERN UNIVERSITY
|
IL
|
$169,875
|
|
Uterine Cancer
|
NCI
|
1R21CA133295-01A1
|
|
FGFR2 MUTATIONS IN INTERMEDIATE RISK ENDOMETRIAL CANCERS
|
GOODFELLOW, PAUL
|
WASHINGTON UNIVERSITY
|
MO
|
$309,653
|
|
Uterine Cancer
|
NCI
|
1R01CA132829-01A1
|
|
Validation and extension of the PREMM Model for mismatch repair gene mutations
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$414,226
|
|
Uterine Cancer
|
NCI
|
2U54CA096297-06A1
|
0011
|
Pilot Project A
|
TORTOLERO-LUNA, GUILLERMO
|
UNIVERSITY OF PUERTO RICO
|
PR
|
$63,241
|
|
Uterine Cancer
|
NCI
|
2U54CA096300-06A1
|
9003
|
Developmental Core- Pilot Projects, Full Projects, Biostat Core and Outreach Prog
|
DUBOIS, RAYMOND
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$597,025
|
|
Uterine Cancer
|
NCRR
|
5M01RR000096-47
|
8565
|
GOG-0210: A MOLECULAR STAGING STUDY OF ENDOMETRIAL CARCINOMA
|
BLANK, SALLY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$406
|
|
Uterine Cancer
|
NCRR
|
5M01RR000096-47
|
8571
|
CLINICAL TRIAL: GOG-0209: COMPARING TWO REGIMENS IN PATIENTS WITH ENDOMETRIAL CA
|
BLANK, SALLY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$3,250
|
|
Uterine Cancer
|
NCRR
|
5M01RR000847-35
|
8693
|
IMPACT OF OBESITY AND PHYSICAL ACTIVITY ON ENDOMETRIAL CANCER GENESIS
|
MODESITT, SUSAN
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$12,065
|
|
Uterine Cancer
|
NCRR
|
5M01RR010732-14
|
5015
|
DEVELOPMENT OF A SCREENING TEST FOR ENDOMETRIAL HYPERPLASIA IN AN AT RISK COHORT
|
LEGRO, RICHARD
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$5,274
|
|
Uterine Cancer
|
NCI
|
1Z01BC005177-28
|
|
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA
|
POIRIER, MIRIAM
|
NIH
|
|
$909,452
|
|
Uterine Cancer
|
NCI
|
1Z01BC010797-02
|
|
Mechanisms of Stromal Cell Activation by the Developing Tumor
|
NIEDERHUBER, JOHN
|
NIH
|
|
$311,930
|
|
Uterine Cancer
|
NCI
|
1Z01CP010126-13
|
|
Hormone-Related Cancers
|
BRINTON, LOUISE
|
NIH
|
|
$4,595,689
|
|
Uterine Cancer
|
NHGRI
|
1Z01HG200338-02
|
|
Genetic Analyses of Endometrial Cancer
|
BELL, DAPHNE
|
NIH
|
|
$921,382
|
|
Uterine Cancer
|
NCI
|
1Z01SC000181-16
|
|
The Molecular Genetics of Gynecologic Cancers
|
BIRRER, MICHAEL
|
NIH
|
|
$576,752
|
